Delivery Order SPE2DB20D3103-SPE2DB23FP7E2
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order valued at $1,111.69 for the supply of 300 mg Gabapentin capsules. It is a Firm Fixed Price contract with a performance period through July 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,463.65 firm fixed-price delivery order is for the supply of 4,565,020,856 capsules of the medication Gabapentin 300 mg. The contract has a completion date of June 28, 2024 and was awarded on June 27, 2024. There was no set-aside designation used for this award. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,702,489 units of gabapentin 300 mg capsules. The $1,349.23 firm-fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,507.38, is a Firm Fixed Price Delivery Order for the supply of Gabapentin 300 mg capsules. The contract has a period of performance through May 28, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans...
- This federal contract award, valued at $2,814.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a completion date of March 12, 2024, is a Delivery Order for the supply of GABAPENTIN 300 MG CAPSULE 1000S. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider, to deliver Gabapentin 300 mg capsules. The $1,284.66 Firm Fixed Price Delivery Order contract has an ultimate completion date of January 24, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,091.13 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4564677665 GABAPENTIN 600 MG TABLET 500S, a pharmaceutical product, with a period of performance through May 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier of medical products to the U.S. government. The $3,585.36 Firm Fixed Price Delivery Order is for the provision of 4565089719 - Gabapentin 600 mg Tablet, with an ultimate completion date of July 9, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,443.41 for the supply of the pharmaceutical product Gabapentin 800 mg tablets. The contract has a period of performance through March 20, 2024 and does not utilize any set-aside...
- This federal contract award is for the delivery of pharmaceutical products, specifically Gabapentin 600 mg tablets, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,166.10 and a completion date of March 2, 2022. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP7E2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,164.96 delivery order contract is for the supply of Gabapentin 300 mg capsules. The contract has a firm fixed price pricing structure and a period of performance through September 14, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/13/23 |